Investigating the effect of tranexamic acid with gelfoam carrier in preventing dry cavity syndrome

Investigating the effect of tranexamic acid with gelfoam carrier in preventing dry cavity syndrome following surgical extraction of impacted mandibular third molar.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230604058381N1

Enrollment

Registered

2023-06-24

Start date

2023-06-26

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry socket. Other diseases of jaws

Interventions

Intervention 1: All patients undergo wisdom tooth extraction surgery by one person. The type of cut in all operations is similar and buccal flap type with distobuccal releasing, along with sulcular cu

Eligibility

Sex/Gender

All

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: age between 18 and 35 years the impacted third molars of the mandible bilateral placed in class I, II and III, level A, B and C based on the classification of Paul and Gary Gouri eed to remove the tooth surgically

Exclusion criteria

Exclusion criteria: Users of exogenous contortionists the presence of systemic disorders respiratory and digestive diseases pregnant women and lactating mothers systemic fungal infections acute infections and active or silent tuberculosis

Design outcomes

Primary

Measure	Time frame
Occurrence or absence of dry socket syndrome. Timepoint: Two or three days after surgery on both intervention and control sides. Method of measurement: Evaluation through clinical observation by maxillofacial surgeon.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Mesgari

Islamic Azad University

kmesgari@gmail.com+98 21 2256 4571

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026